Short-acting inhaled beta-2-agonists increased the mortality from chronic obstructive pulmonary disease in observational designs

Article ID	Journal	Published Year	Pages	File Type
10514920	Journal of Clinical Epidemiology	2005	6 Pages	PDF

Abstract

Evidence that higher doses of short-acting inhaled Î²2-agonists are associated with higher mortality from COPD was consistently supplied by three observational approaches.

Keywords

Automated databases Beta-agonists Chronic obstructive pulmonary disease Case-crossover design Case-control

Related Topics

Health Sciences Medicine and Dentistry Public Health and Health Policy

Preview

Short-acting inhaled beta-2-agonists increased the mortality from chronic obstructive pulmonary disease in observational designs

Authors

Giovanni Corrao, Antonella Zambon, Silvia Faini, Vincenzo Bagnardi, Olivia Leoni, Samy Suissa,